Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis

BACKGROUND: Reactivation of hepatitis B virus (HBV) replication is a well-recognised complication in patients receiving disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA). Limited data exist on HBV reactivation among patients with RA treated with janus kinase (JAK) inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Harigai, Masayoshi, Winthrop, Kevin, Takeuchi, Tsutomu, Hsieh, Tsu-Yi, Chen, Yi-Ming, Smolen, Josef S, Burmester, Gerd, Walls, Chad, Wu, Wen-Shuo, Dickson, Christina, Liao, Ran, Genovese, Mark C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046961/
https://www.ncbi.nlm.nih.gov/pubmed/32098857
http://dx.doi.org/10.1136/rmdopen-2019-001095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046961/
https://www.ncbi.nlm.nih.gov/pubmed/32098857
http://dx.doi.org/10.1136/rmdopen-2019-001095

Ejemplares similares